Match!

Effect of Pioglitazone on Abdominal Fat Distribution and Insulin Sensitivity in Type 2 Diabetic Patients

Published on Jun 1, 2002in The Journal of Clinical Endocrinology and Metabolism5.605
· DOI :10.1210/jc.87.6.2784
Yoshinori Miyazaki20
Estimated H-index: 20
(UTSA: University of Texas at San Antonio),
Archana Mahankali8
Estimated H-index: 8
(University of Texas Health Science Center at San Antonio)
+ 5 AuthorsRalph A. DeFronzo142
Estimated H-index: 142
(University of Texas Health Science Center at San Antonio)
Abstract
We examined the effect of pioglitazone on abdominal fat distribution to elucidate the mechanisms via which pioglitazone improves insulin resistance in patients with type 2 diabetes mellitus. Thirteen type 2 diabetic patients (nine men and four women; age, 52 ± 3 yr; body mass index, 29.0 ± 1.1 kg/m2), who were being treated with a stable dose of sulfonylurea (n = 7) or with diet alone (n = 6), received pioglitazone (45 mg/d) for 16 wk. Before and after pioglitazone treatment, subjects underwent a 75-g oral glucose tolerance test (OGTT) and two-step euglycemic insulin clamp (insulin infusion rates, 40 and 160 mU/m2·min) with [3H]glucose. Abdominal fat distribution was evaluated using magnetic resonance imaging at L4–5. After 16 wk of pioglitazone treatment, fasting plasma glucose (179 ± 10 to 140 ± 10 mg/dl; P < 0.01), mean plasma glucose during OGTT (295 ± 13 to 233 ± 14 mg/dl; P < 0.01), and hemoglobin A1c (8.6 ± 0.4% to 7.2 ± 0.5%; P < 0.01) decreased without a change in fasting or post-OGTT insulin lev...
  • References (45)
  • Citations (565)
📖 Papers frequently viewed together
200 Citations
199915.27Diabetes Care
286 Citations
199915.27Diabetes Care
7 Authors (Yutaka Mori, ..., Yoshio Ikeda)
246 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References45
Newest
#1Robert Steele (BNL: Brookhaven National Laboratory)H-Index: 6
1,445 CitationsSource
#1Claire M. Steppan (UPenn: University of Pennsylvania)H-Index: 21
#2Shannon T. Bailey (UPenn: University of Pennsylvania)H-Index: 17
Last. Mitchell A. Lazar (UPenn: University of Pennsylvania)H-Index: 117
view all 9 authors...
Diabetes mellitus is a chronic disease that leads to complications including heart disease, stroke, kidney failure, blindness and nerve damage. Type 2 diabetes, characterized by target-tissue resistance to insulin, is epidemic in industrialized societies and is strongly associated with obesity; however, the mechanism by which increased adiposity causes insulin resistance is unclear. Here we show that adipocytes secrete a unique signalling molecule, which we have named resistin (for resistance to...
3,676 CitationsSource
#1Vivian FonsecaH-Index: 12
#2Howard L. FoytH-Index: 2
Last. Randall W. WhitcombH-Index: 4
view all 4 authors...
OBJECTIVE: To determine the long-term effects of troglitazone as monotherapy or in combination with sulfonylureas or insulin regarding glycemic and lipid measures. RESEARCH DESIGN AND METHODS: Patients who completed one of three double-blind studies (a 6-month troglitazone monotherapy study, a 52-week study of troglitazone in combination with micronized glyburide, or a 6-month study of troglitazone in combination with insulin) were allowed to enter open-label extensions of their respective doubl...
36 CitationsSource
#1Juan P. FriasH-Index: 23
#2Joseph G. YuH-Index: 12
Last. Jerrold M. OlefskyH-Index: 127
view all 4 authors...
OBJECTIVE: To characterize metabolic effects of troglitazone in type 2 diabetic, obese, and lean subjects, and examine the effects of troglitazone 2-3 weeks after discontinuation. RESEARCH DESIGN AND METHODS: Nine type 2 diabetic, nine obese, and nine lean subjects underwent baseline metabolic studies including an 8-h meal-tolerance test (MTT) and a 5-h glucose clamp. Subjects then received troglitazone (600 mg/day) for 12 weeks and subsequently had repeat metabolic studies. Diabetic subjects re...
50 CitationsSource
#1Masafumi Matsuda (University of Texas Health Science Center at San Antonio)H-Index: 30
#2Ralph A. DeFronzoH-Index: 142
OBJECTIVE: Several methods have been proposed to evaluate insulin sensitivity from the data obtained from the oral glucose tolerance test (OGTT). However, the validity of these indices has not been rigorously evaluated by comparing them with the direct measurement of insulin sensitivity obtained with the euglycemic insulin clamp technique. In this study, we compare various insulin sensitivity indices derived from the OGTT with whole-body insulin sensitivity measured by the euglycemic insulin cla...
3,691 CitationsSource
#1Johan Auwerx (Pasteur Institute)H-Index: 141
The peroxisome proliferator-activated receptor gamma (PPARgamma) quickly evolved over the last decade from a new orphan receptor to one of the best characterized nuclear receptors. This fast pace in PPARgamma research was triggered by two main discoveries. Firstly, that PPARgamma was shown to have a key role in adipogenesis and be a master controller of the "thrifty gene response" leading to efficient energy storage. Secondly, the discovery that its synthetic ligands, the thiazolidinediones, are...
543 CitationsSource
#1Yutaka MoriH-Index: 18
#2Y MurakawaH-Index: 1
Last. Yoshio IkedaH-Index: 15
view all 7 authors...
OBJECTIVE: Troglitazone was recently reported to specifically promote the differentiation of pre-adipocytes into adipocytes in vitro in subcutaneous fat only, indicating a relation to insulin-resistance-improving action of troglitazone. To expand on this finding, we investigated at the clinical level how long-term administration of troglitazone influences the body fat distribution in type 2 diabetic patients. RESEARCH DESIGN AND METHODS: Troglitazone (400 mg/day) was administered for 6 months to...
246 CitationsSource
#1J. Patel (Creighton University)H-Index: 1
#2R. J. Anderson (Creighton University)H-Index: 1
Last. E. B. Rappaport (Creighton University)H-Index: 1
view all 3 authors...
Summary Aim: Rosiglitazone is the most potent of the thiazolidinediones, a novel class of oral antidiabetic agents that reduce blood glucose levels by sensitizing peripheral tissues to insulin. This study was designed to identify doses of rosiglitazone that would lower fasting plasma glucose (FPG) in patients with type 2 diabetes. Methods: In this 12-week, double-blind, multicentre study, 380 patients with FPG values ≥7.8 mmol/L (140 mg/dL) and ≤13.3 mmol/L (240 mg/dL) were randomly assigned to ...
174 CitationsSource
#1Xinhua ChenH-Index: 21
#2Nayyar IqbalH-Index: 22
Last. Guenther BodenH-Index: 62
view all 3 authors...
We have quantitatively determined gluconeogenesis (GNG) from all precursors, using a novel method employing 2H20 to address the question of whether changes in plasma free fatty acids (FFA) affect GNG in healthy, nonobese subjects. In the first study (n = 6), plasma FFA were lowered at 16 to 20 hours with nicotinic acid (NA) and were then allowed to rise at 20 to 24 hours (FFA rebound after administration of NA). FFA decreased from 387 μM at 16 hours to 43 μM at 20 hours, and then rebounded to 1,...
232 CitationsSource
#1Karin Ekberg (KI: Karolinska Institutet)H-Index: 31
#2Bernard R. Landau (Case Western Reserve University)H-Index: 40
Last. J. Wahren (KI: Karolinska Institutet)H-Index: 69
view all 7 authors...
Contributions of renal glucose production to whole-body glucose turnover were determined in healthy individuals by using the arteriovenous balance technique across the kidneys and the splanchnic area combined with intravenous infusion of [U-13C6]glucose, [3-(3)H]glucose, or [6-(3)H]glucose. In the postabsorptive state, the rate of glucose appearance was 11.5 +/- 0.6 micromol x kg(-1) x min(-1). Hepatic glucose production, calculated as the sum of net glucose output (9.8 +/- 0.8 micromol x kg(-1)...
188 CitationsSource
Cited By565
Newest
Summary An increase in fat mass is considered to be an important risk factor for the worldwide increase in type 2 diabetes and cardiovascular disease. However, for a given fat mass, there is a large variability in the risk prediction of these cardiometabolic diseases. For example, some lean people unexpectedly have a risk of type 2 diabetes and cardiovascular disease that is similar to the increased risk that is observed in most people who have obesity. What both of these phenotypes have in comm...
1 CitationsSource
#1Yue Zhou (Qingdao University)H-Index: 2
#2Yajing Huang (Qingdao University)H-Index: 1
Last. Yangang Wang (Qingdao University)H-Index: 19
view all 6 authors...
CONTEXT: The goal of the meta-analysis was to evaluate the effect of pioglitazone on the primary and secondary prevention of cardiovascular diseases (CVDs) and renal adverse events in patients with or at high risk of type 2 diabetes mellitus (T2DM). DESIGN: Randomized controlled trials (RCTs) comparing pioglitazone with any control were identified through PubMed, Embase, and the Cochrane Library. Cardiovascular outcomes included major adverse cardiovascular events (MACEs, defined as the composit...
1 CitationsSource
#1Ravi Choxi (VCU: Virginia Commonwealth University)
#2Sumon Roy (VCU: Virginia Commonwealth University)
Last. Ion S. Jovin (VCU: Virginia Commonwealth University)H-Index: 18
view all 5 authors...
Introduction: Type 2 diabetes mellitus and cardiovascular disease contribute to significant morbidity, mortality, and health care resource expenditure. The pathophysiological and clinical associations between diabetes and cardiovascular disease have been the subject of multiple studies, most recently culminating in large trials of several new anti-glycemic agents being found to confer additional cardiovascular risk reduction. Understanding the potential cardiovascular benefits of anti-glycemic m...
Source
#1Alan Chait (UW: University of Washington)H-Index: 76
#2Laura J. den Hartigh (UW: University of Washington)H-Index: 12
Adipose tissue plays essential roles in maintaining lipid and glucose homeostasis. To date several types of adipose tissue have been identified, namely white, brown, and beige, that reside in various specific anatomical locations throughout the body. The cellular composition, secretome, and location of these adipose depots define their function in health and metabolic disease. In obesity, adipose tissue becomes dysfunctional, promoting a pro-inflammatory, hyperlipidemic and insulin resistant env...
10 CitationsSource
#1Peter M. Masschelin (BCM: Baylor College of Medicine)H-Index: 2
#2Aaron R. Cox (BCM: Baylor College of Medicine)H-Index: 9
Last. Sean M. Hartig (BCM: Baylor College of Medicine)H-Index: 18
view all 4 authors...
Overnutrition and sedentary activity reinforce the growing trend of worldwide obesity, insulin resistance, and type 2 diabetes. However, we have limited insight into how food intake generates the complex metabolic perturbations associated with obesity. Accumulation of mitochondrial oxidative stress contributes to the metabolic changes in obesity, but the mechanisms and significance are unclear. In white adipose tissue (WAT), mitochondrial oxidative stress and the generation of reactive oxygen sp...
2 CitationsSource
#1Injae Hwang (SNU: Seoul National University)H-Index: 5
#1Injae Hwang (SNU: Seoul National University)
Last. Jae Bum Kim (SNU: Seoul National University)
view all 2 authors...
Chronic energy surplus increases body fat, leading to obesity. Since obesity is closely associated with most metabolic complications, pathophysiological roles of adipose tissue in obesity have been intensively studied. White adipose tissue is largely divided into subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT). These two white adipose tissues are similar in their appearance and lipid storage functions. Nonetheless, emerging evidence has suggested that SAT and VAT have differe...
2 CitationsSource
#1Fawaz Mzayek (U of M: University of Memphis)H-Index: 20
#2Lisa E. Wang (U of M: University of Memphis)
Last. Adolfo Correa (UMMC: University of Mississippi Medical Center)H-Index: 51
view all 9 authors...
OBJECTIVE: Abdominal obesity and wall thickness of the central arteries have been associated with higher risk of cardiovascular disease. Despite the higher burden of overweight and cardiovascular disease among African Americans, limited data are available on the association of abdominal obesity with aortic wall thickness in African Americans. We assessed the cross-sectional and the longitudinal associations of abdominal obesity with aortic intima-media thickness (aIMT) in a cohort of African Ame...
Source
#1Mohammed E. Al-Sofiani (KSU: King Saud University)H-Index: 2
#2Suneeta Ganji (Johns Hopkins University)H-Index: 1
Last. Rita R. Kalyani (Johns Hopkins University)H-Index: 28
view all 3 authors...
Abstract Aging is associated with changes in body composition, including both fat gain and muscle loss beginning in middle age, and is associated with increased risk of type 2 diabetes. Moreover, changes in fat distribution take place in adults as they age and may contribute to the increased risk of type 2 diabetes. Recent literature has shown differences in the age-related changes in body composition by diabetes status suggesting that some of these changes might not only be a risk factor of the...
1 CitationsSource
#1Antonino Di Pino (University of Texas Health Science Center at San Antonio)H-Index: 1
#2Ralph A. DeFronzo (University of Texas Health Science Center at San Antonio)H-Index: 142
: Patients with type 2 diabetes mellitus (T2DM) are at high risk for macrovascular complications, which represent the major cause of mortality. Despite effective treatment of established cardiovascular (CV) risk factors (dyslipidemia, hypertension, procoagulant state), there remains a significant amount of unexplained CV risk. Insulin resistance is associated with a cluster of cardiometabolic risk factors known collectively as the insulin resistance (metabolic) syndrome (IRS). Considerable evide...
3 CitationsSource
#1Nicholas K.H. Khoo (University of Pittsburgh)H-Index: 20
#2Marco Fazzari (University of Pittsburgh)H-Index: 12
Last. Bruce A. Freeman (University of Pittsburgh)H-Index: 96
view all 8 authors...
Abstract Non-alcoholic fatty liver disease (NAFLD) is linked to obesity and insulin resistance and is the most prevalent chronic liver disease. During the development of obesity and NAFLD, mitochondria adapt to the increased lipid load in hepatocytes by increasing the rate of fatty acid oxidation. In concert with this, reactive species (RS) generation is increased, damaging hepatocytes and inducing inflammation. Hepatic mitochondrial dysfunction is central to the pathogenesis of NAFLD via undefi...
2 CitationsSource